RIVN vs SGMO · rev $1.66B vs rev $57.8M
Rivian Automotive Inc (RIVN) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Rivian Automotive Inc (RIVN) is a auto manufacturers company listed on NASDAQ. It is led by RJ Scaringe.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported RIVN revenue for 2026-06-30 was $1.66B. Net income was -$833.0M. Revenue was up 20.1% from 2026-03-31 to 2026-06-30. RIVN currently screens at market cap $21.81B.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
RIVN currently screens at market cap $21.81B. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the RIVN and SGMO stock pages for the full models.
Not investment advice.